Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E15.39 EPS (ttm)0.68 Insider Own0.94% Shs Outstand494.45M Perf Week-3.73%
Market Cap5.17B Forward P/E10.78 EPS next Y0.97 Insider Trans0.98% Shs Float489.95M Perf Month-9.02%
Income338.00M PEG2.34 EPS next Q0.31 Inst Own100.15% Short Float2.95% Perf Quarter-16.44%
Sales4.44B P/S1.16 EPS this Y-8.48% Inst Trans1.47% Short Ratio3.08 Perf Half Y-29.33%
Book/sh12.33 P/B0.85 EPS next Y16.38% ROA2.51% Short Interest14.46M Perf Year-36.50%
Cash/sh0.95 P/C11.04 EPS next 5Y6.57% ROE5.49% 52W Range10.03 - 18.80 Perf YTD-13.75%
Dividend Est.- P/FCF13.11 EPS past 5Y29.95% ROI3.23% 52W High-44.44% Beta1.45
Dividend TTM- Quick Ratio1.25 Sales past 5Y9.07% Gross Margin43.01% 52W Low4.14% ATR (14)0.45
Dividend Ex-Date- Current Ratio2.44 EPS Y/Y TTM127.38% Oper. Margin5.65% RSI (14)39.92 Volatility3.74% 3.98%
Employees9450 Debt/Eq0.73 Sales Y/Y TTM0.50% Profit Margin7.61% Recom1.88 Target Price15.67
Option/ShortYes / Yes LT Debt/Eq0.72 EPS Q/Q94.34% Payout0.00% Rel Volume0.75 Prev Close10.04
Sales Surprise1.10% EPS Surprise-6.04% Sales Q/Q-1.45% EarningsFeb 25 BMO Avg Volume4.70M Price10.44
SMA20-5.15% SMA50-9.52% SMA200-22.92% Trades Volume3,332,672 Change4.03%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Mar-11-25 11:05PM
Feb-26-25 06:09PM
02:05AM
12:34AM
Feb-25-25 01:38PM
01:15PM Loading…
01:15PM
09:30AM
08:20AM
07:15AM
07:05AM
07:05AM
Feb-24-25 09:16AM
08:05AM
Feb-21-25 08:00AM
Feb-20-25 12:05PM
08:27AM Loading…
08:27AM
Feb-13-25 04:29PM
Feb-10-25 12:17PM
Feb-04-25 08:00AM
Feb-03-25 12:18AM
Jan-30-25 02:45PM
Jan-27-25 08:06AM
Jan-23-25 08:27AM
Jan-12-25 09:38AM
Jan-10-25 12:30PM
Dec-19-24 11:07AM
Dec-01-24 09:08AM
Nov-29-24 12:18PM
Nov-27-24 01:45PM
Nov-26-24 07:22AM
04:31AM Loading…
04:31AM
Nov-25-24 08:45AM
08:00AM
Nov-24-24 11:33AM
Nov-23-24 07:23AM
Nov-21-24 10:46AM
Nov-20-24 08:53AM
Nov-18-24 02:52PM
Nov-15-24 11:30AM
Nov-14-24 03:15PM
Nov-13-24 01:39PM
Nov-12-24 07:20PM
08:33AM
05:45AM
Nov-11-24 04:02PM
Nov-08-24 04:03AM
02:09AM
02:03AM
Nov-07-24 04:30PM
03:28PM
12:41PM
09:30AM
08:52AM
07:35AM
06:27AM
Nov-05-24 07:38AM
Nov-04-24 03:51PM
09:16AM
Nov-01-24 05:45AM
Oct-31-24 01:42PM
10:01AM
Oct-30-24 11:46AM
Oct-28-24 07:17PM
Oct-25-24 09:56AM
Oct-24-24 02:29PM
Oct-23-24 10:16AM
Oct-22-24 10:42AM
Oct-21-24 06:12PM
Oct-17-24 12:14PM
12:10PM
Oct-16-24 11:21AM
08:54AM
Oct-11-24 09:14AM
Oct-10-24 08:00AM
Oct-09-24 11:23AM
Oct-08-24 08:43PM
Oct-07-24 04:19PM
Sep-20-24 10:35AM
Sep-19-24 03:08PM
01:42PM
12:50PM
Sep-13-24 07:30AM
Aug-28-24 06:30AM
Aug-20-24 06:27AM
Aug-15-24 08:27AM
Aug-13-24 01:49PM
Aug-09-24 02:35AM
Aug-08-24 03:45PM
09:30AM
07:35AM
06:28AM
Aug-06-24 01:00PM
Aug-05-24 09:16AM
Aug-01-24 03:14PM
10:01AM
Jul-30-24 08:27AM
Jul-25-24 01:18PM
Jul-22-24 02:42PM
10:18AM
Jul-18-24 08:00AM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence ErikDirectorMar 07 '25Buy10.9010,000109,000101,459Mar 11 05:13 PM
Kurzius Lawrence ErikDirectorMar 11 '25Buy10.2010,000102,000111,459Mar 11 05:13 PM
HOOVER R DAVIDDirectorMar 05 '25Buy10.9025,000272,558210,000Mar 07 04:21 PM
Harrington Michael JDirectorAug 22 '24Buy14.853,50051,97481,094Aug 26 05:05 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORAug 12 '24Buy13.01100,0001,300,610145,000Aug 13 09:04 AM
DOYLE WILLIAM FDirectorMay 21 '24Buy16.9815,000254,70076,330May 23 04:33 PM
Last Close
Mar 12 03:40PM ET
81.65
Dollar change
-1.53
Percentage change
-1.84
%
MKC McCormick & Co., Inc daily Stock Chart
IndexS&P 500 P/E27.93 EPS (ttm)2.92 Insider Own6.02% Shs Outstand252.30M Perf Week-1.30%
Market Cap21.90B Forward P/E24.57 EPS next Y3.32 Insider Trans-0.60% Shs Float252.00M Perf Month6.50%
Income788.50M PEG4.02 EPS next Q0.64 Inst Own82.23% Short Float2.61% Perf Quarter5.36%
Sales6.72B P/S3.26 EPS this Y3.95% Inst Trans2.77% Short Ratio3.25 Perf Half Y-1.91%
Book/sh19.74 P/B4.14 EPS next Y8.35% ROA6.08% Short Interest6.57M Perf Year19.06%
Cash/sh0.69 P/C117.70 EPS next 5Y6.94% ROE15.23% 52W Range66.88 - 86.24 Perf YTD7.10%
Dividend Est.1.81 (2.22%) P/FCF33.86 EPS past 5Y2.22% ROI8.71% 52W High-5.32% Beta0.74
Dividend TTM1.71 (2.09%) Quick Ratio0.31 Sales past 5Y4.78% Gross Margin38.51% 52W Low22.08% ATR (14)2.13
Dividend Ex-DateDec 30, 2024 Current Ratio0.74 EPS Y/Y TTM15.79% Oper. Margin15.89% RSI (14)53.89 Volatility2.71% 2.64%
Employees14100 Debt/Eq0.86 Sales Y/Y TTM0.92% Profit Margin11.73% Recom2.50 Target Price85.75
Option/ShortYes / Yes LT Debt/Eq0.71 EPS Q/Q-1.91% Payout57.44% Rel Volume0.74 Prev Close83.18
Sales Surprise1.42% EPS Surprise4.07% Sales Q/Q2.58% EarningsMar 25 BMO Avg Volume2.02M Price81.65
SMA200.99% SMA505.28% SMA2006.00% Trades Volume1,430,789 Change-1.84%
Date Action Analyst Rating Change Price Target Change
Jan-08-25Upgrade TD Cowen Hold → Buy $86 → $90
Dec-09-24Upgrade Jefferies Hold → Buy $85 → $91
Jun-12-24Upgrade Citigroup Sell → Neutral $68 → $69
Apr-02-24Upgrade Argus Hold → Buy
Feb-01-24Initiated Citigroup Sell $60
Jan-22-24Downgrade Consumer Edge Research Overweight → Equal Weight
Sep-22-23Initiated HSBC Securities Hold $86
Sep-13-23Initiated TD Cowen Market Perform $87
Jun-06-23Upgrade BofA Securities Underperform → Buy $75 → $100
Apr-14-23Resumed Stifel Hold $82
Mar-11-25 06:38PM
Mar-02-25 10:24AM
Feb-26-25 08:55AM
Feb-04-25 03:15PM
Jan-28-25 04:30PM
07:25PM Loading…
Jan-27-25 07:25PM
Jan-23-25 10:37AM
06:30AM
Jan-10-25 07:23PM
Jan-02-25 04:30PM
04:30PM
Nov-25-24 08:15AM
08:15AM
Nov-19-24 05:15PM
Oct-27-24 08:30AM
08:30AM Loading…
Oct-24-24 08:30AM
Oct-23-24 02:04PM
08:24AM
Oct-22-24 06:29PM
05:46PM
Oct-17-24 04:30PM
Oct-08-24 02:27PM
Oct-01-24 01:09PM
01:04PM
11:59AM
06:30AM
Sep-30-24 05:03PM
Sep-24-24 04:35PM
Sep-16-24 07:02PM
Aug-29-24 04:30PM
04:30PM Loading…
Aug-15-24 04:30PM
Aug-14-24 04:53PM
Jul-26-24 07:15PM
Jul-16-24 10:43AM
Jul-01-24 06:16AM
Jun-28-24 09:14AM
08:03AM
Jun-27-24 05:08PM
04:49PM
02:02PM
12:50PM
12:13PM
11:00AM
10:52AM
09:48AM
09:30AM
07:40AM
06:45AM
06:30AM
Jun-26-24 05:06PM
04:56PM
12:58PM
Jun-25-24 04:50PM
Jun-24-24 09:15AM
Jun-21-24 09:00AM
Jun-20-24 10:00AM
Jun-19-24 11:44AM
Jun-18-24 11:56AM
Jun-10-24 05:33AM
Jun-05-24 10:05AM
May-30-24 08:00AM
May-29-24 05:30AM
May-28-24 07:41PM
May-22-24 06:15AM
May-21-24 05:10PM
May-20-24 06:15AM
May-17-24 08:00AM
May-15-24 10:35AM
May-14-24 04:50PM
May-06-24 02:00PM
May-02-24 02:20PM
Apr-30-24 03:32PM
02:48PM
Apr-25-24 11:30AM
Apr-22-24 12:53PM
Apr-16-24 03:19AM
Apr-02-24 04:50PM
08:00AM
Mar-28-24 01:54PM
Mar-27-24 04:40PM
12:54PM
Mar-26-24 05:11PM
01:23PM
12:50PM
11:05AM
10:53AM
10:17AM
10:07AM
09:32AM
07:03AM
06:30AM
Mar-25-24 05:11PM
Mar-24-24 10:58AM
07:56AM
Mar-22-24 04:31PM
Mar-21-24 12:28PM
Mar-19-24 10:00AM
Mar-14-24 06:05AM
Feb-29-24 08:00AM
Feb-28-24 03:40PM
McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRESTON MARGARET M VDirectorFeb 13 '25Sale77.0328,0922,163,9276,177Feb 14 10:12 AM
Tapiero JacquesDirectorFeb 03 '25Option Exercise78.0370755,16329,102Feb 04 03:30 PM
Kurzius Lawrence ErikDirectorFeb 03 '25Option Exercise49.9650,0002,498,000326,895Feb 04 03:15 PM
Kurzius Lawrence ErikDirectorFeb 03 '25Sale76.8150,0003,840,320276,895Feb 04 03:15 PM
Tapiero JacquesDirectorNov 11 '24Option Exercise38.155,000190,72533,217Nov 12 12:58 PM
Tapiero JacquesDirectorNov 11 '24Sale77.345,000386,70228,217Nov 12 12:58 PM
MANGAN MICHAEL DDirectorNov 06 '24Option Exercise38.155,000190,72545,436Nov 08 08:35 AM
MANGAN MICHAEL DDirectorNov 06 '24Sale79.005,000395,00040,436Nov 08 08:35 AM
Tapiero JacquesDirectorNov 04 '24Option Exercise38.155,000190,72533,217Nov 05 10:59 AM
Tapiero JacquesDirectorNov 04 '24Sale78.335,000391,67228,217Nov 05 10:59 AM
MANGAN MICHAEL DDirectorNov 01 '24Option Exercise38.155,000190,72545,436Nov 04 12:50 PM
MANGAN MICHAEL DDirectorNov 01 '24Sale78.505,000392,50040,436Nov 04 12:50 PM
Montiel Maritza GomezDirectorAug 15 '24Option Exercise49.319,816484,03412,410Aug 15 04:45 PM
Montiel Maritza GomezDirectorAug 15 '24Sale76.849,816754,3075,594Aug 15 04:45 PM
Kurzius Lawrence ErikDirectorJul 17 '24Sale75.0025,0001,875,0000Jul 17 01:27 PM
Kurzius Lawrence ErikDirectorMay 21 '24Option Exercise38.1580,0003,051,600279,258May 22 12:02 PM
Kurzius Lawrence ErikDirectorMay 21 '24Sale73.7580,0005,900,024199,258May 22 12:02 PM
Jenkins KatherineChief Growth OfficerMay 14 '24Sale75.912,732207,3900May 14 04:53 PM
Jenkins KatherineChief Growth OfficerApr 22 '24Sale74.351,726128,3260Apr 23 05:15 PM
LITTLE PATRICIA ADirectorApr 01 '24Option Exercise44.0520,000881,05034,732Apr 02 01:18 PM
LITTLE PATRICIA ADirectorApr 01 '24Sale75.5720,0001,511,44524,732Apr 02 01:18 PM
Montiel Maritza GomezDirectorMar 28 '24Option Exercise49.967,000349,72012,594Mar 29 12:12 PM
Montiel Maritza GomezDirectorMar 28 '24Sale77.007,000538,9865,594Mar 29 12:12 PM
PRESTON MARGARET M VDirectorMar 15 '24Option Exercise0.001,255098,864Mar 19 03:49 PM
BRAMMAN ANNE LDirectorMar 15 '24Option Exercise0.001,25505,239Mar 19 03:39 PM
HRABOWSKI FREEMAN A IIIDirectorMar 15 '24Option Exercise0.001,2550102,456Mar 19 02:56 PM
Montiel Maritza GomezDirectorMar 15 '24Option Exercise0.001,25505,594Mar 19 02:54 PM
LITTLE PATRICIA ADirectorMar 15 '24Option Exercise0.001,255024,732Mar 19 02:52 PM
Jenkins KatherineChief Growth OfficerMar 15 '24Option Exercise0.0080203,383Mar 19 02:28 PM
Foust AndrewPresident, AmericasMar 15 '24Option Exercise0.001,23905,406Mar 19 02:25 PM
Piper SarahChief Human Relations OfficerMar 15 '24Option Exercise0.0036702,177Mar 19 02:22 PM
Sanchez AnaPresident EMEAMar 15 '24Option Exercise0.0080103,818Mar 19 02:20 PM